Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 100   

Articles published

NVS 89.84 +0.11 (0.12%)
price chart
United Therapeutics Wins Against Novartis In Court Ruling
United Therapeutics Inc. (UTHR) stock rallied 28.5% yesterday on news that the biopharmaceutical company has received a favorable court ruling in a patent fight with Novartis AG (NVS). In 2011, Sandoz International, Novartis' subsidiary, announced ...
Related articles »  
Teva's Patent Problems Continue
Yesterday, Mylan Inc (MYL) and the duo of Novartis AG (ADR) (NVS)'s Sandoz unit and Momenta Pharmaceuticals, Inc (MNTA) announced that they have filed an Abbreviated New Drug Application (ANAD) for the Copaxone 40mg/mL with the US Food and ...
Related articles »  
Novartis's Generics Unit May Benefit From Biomedicine Patent Expiry
Switzerland-based Novartis AG's (NVS) generic unit goes by the name of Sandoz, and it is the number one player in biosimilars.
Related articles »  
Novartis Takes Stake In Gamida Cell With Option To Acquire
Novartis AG (ADR) (NVS) has signed an agreement with Gamida Cell to invest $35 million in the Israel-based stem cell biotech company.
Related articles »  
Novartis, Global Alliance Collaborate To Search For TB Cure
Switzerland-based Novartis AG (ADR) (NVS) signed a deal today to license its experimental drugs for the treatment of tuberculosis (TB) to the Global Alliance for TB Drug Development (TB Alliance).
Related articles »  
Safest Dividend Stocks In The Market
Novartis is a perfect selection because it has a slew of pharmaceutical products and always is on the hunt for new ones. Like Merck, that means consistent and reliable cash flow, which means consistent and reliable dividends.
Novartis' New Heart Drug Expected To Be A Hit
Based on the approval from the ESC, Novartis aims to release the drug on the market as soon as possible. On a related note, the current annual global spending on the treatment of cardiovascular diseases is $45 billion; the figure is estimated grow to ...
Related articles »  
Stocks to Keep Your Eyes on: Novartis AG (ADR) (NYSE:NVS), Vornado Realty ...
Las Vegas, NV - August 28, 2014 - (Tech Sonian) ´┐ŻNovartis AG (ADR) (NVS), offers patented prescription medicines in a variety of therapeutic areas, including oncology; most important care and established medicines; specialty care, such as ...
Related articles »  
Active Movers - Novartis AG (ADR) (NYSE:NVS), Alkermes Plc (NASDAQ:ALKS ...
Manhattan, NY- 16 AUG, 2014 - (Techsonian) - Novartis AG (ADR) (NYSE:NVS)released thatBiotechnology stocks were among the top performers in 2012 and 2013.
Hospira Granted Restraining Order Against FDA Approval Of Generics
Novartis AG's (ADR) (NVS) unit Sandoz backed Hospira's stance; Sandoz and Hospira had reached a settlement over patent disputes earlier this year.
Related articles »